Research and Development

HBT’s extensive product pipeline focuses on injectable pharmaceutical products to treat disease, including cancer and CNS disorders. HBT Labs has extensive technical experience in the development of complex therapeutics and aseptic manufacturing techniques. Its R&D efforts are focused on the development of generic products whose profiles present difficult technical challenges.
Our mission is to develop and deliver cost-effective, high-quality therapeutics for patients in critical need.